Further pressure on PBMs over 'absorbing rebates and discounts'

A group of the three biggest state rheumatology organizations have joined a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.

The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent and Affordable Prescriptions (ATAP).

"Regular and steep price hikes coupled with opaque negotiations between pharmaceutical companies and PBMs are increasingly presenting unnecessary obstacles to access"